Multimerin 1

References

• George J, Colman R. Overview of platelet structure and function. Hemostasis and thrombosis: Basic principles and clinical practice, RW Colman, VJ Marder, A Clowes, JN George, SZ Goldhaber. Lippincott and Williams, Philadelphia 2006; 437–442
   Google Scholar
• Datta YH, Ewenstein BM. Regulated secretion in endothelial cells: Biology and clinical implications. Thromb Haemost 2001; 86: 1148–1155
   PubMed Web of Science ®Google Scholar
• Harrison P, Cramer EM. Platelet alpha-granules. Blood Rev 1993; 7: 52–62
   PubMed Web of Science ®Google Scholar
• Polasek J. Procoagulant potential of platelet alpha granules. Platelets 2004; 15: 403–407
   PubMed Web of Science ®Google Scholar
• Hayward CP, Smith JW, Horsewood P, Warkentin TE, Kelton JG. p-155, a multimeric platelet protein that is expressed on activated platelets. J Biol Chem 1991; 266: 7114–7120
   PubMedGoogle Scholar
• Hayward CP, Warkentin TE, Horsewood P, Kelton JG. Multimerin: A series of large disulfide-linked multimeric proteins within platelets. Blood 1991; 77: 2556–2560
   PubMedGoogle Scholar
• Hayward CP, Bainton DF, Smith JW, Horsewood P, Stead RH, Podor TJ, Warkentin TE, Kelton JG. Multimerin is found in the alpha-granules of resting platelets and is synthesized by a megakaryocytic cell line. J Clin Invest 1993; 91: 2630–2639
   PubMedGoogle Scholar
• Hayward CP, Hassell JA, Denomme GA, Rachubinski RA, Brown C, Kelton JG. The cDNA sequence of human endothelial cell multimerin. A unique protein with RGDS, coiled-coil, and epidermal growth factor-like domains and a carboxyl terminus similar to the globular domain of complement C1q and collagens type VIII and X. J Biol Chem 1995; 270: 18246–18251
   PubMed Web of Science ®Google Scholar
• Hayward CP, Kelton JG. Multimerin. Curr Opin Hematol 1995; 2: 339–344
   PubMedGoogle Scholar
• Hayward CP, Furmaniak-Kazmierczak E, Cieutat AM, Moore JC, Bainton DF, Nesheim ME, Kelton JG, Cote G. Factor V is complexed with multimerin in resting platelet lysates and colocalizes with multimerin in platelet alpha-granules. J Biol Chem 1995; 270: 19217–19224
   PubMedGoogle Scholar
• Hayward CP, Rivard GE, Kane WH, Drouin J, Zheng S, Moore JC, Kelton JG. An autosomal dominant, qualitative platelet disorder associated with multimerin deficiency, abnormalities in platelet factor V, thrombospondin, von Willebrand factor, and fibrinogen and an epinephrine aggregation defect. Blood 1996; 87: 4967–4978
   PubMed Web of Science ®Google Scholar
• Hayward CP, Cramer EM, Kane WH, Zheng S, Bouchard M, Masse JM, Rivard GE. Studies of a second family with the Quebec platelet disorder: Evidence that the degradation of the alpha-granule membrane and its soluble contents are not secondary to a defect in targeting proteins to alpha-granules. Blood 1997; 89: 1243–1253
   PubMedGoogle Scholar
• Hayward CP. Multimerin: A bench-to-bedside chronology of a unique platelet and endothelial cell protein–from discovery to function to abnormalities in disease. Clin Invest Med 1997; 20: 176–187
   PubMedGoogle Scholar
• Hayward CP, Cramer EM, Song Z, Zheng S, Fung R, Masse JM, Stead RH, Podor TJ. Studies of multimerin in human endothelial cells. Blood 1998; 91: 1304–1317
   PubMedGoogle Scholar
• Chen CI, Federici AB, Cramer EM, Canciani MT, Harrison P, Zheng S, Masse JM, Mannucci PM, Hayward CP. Studies of multimerin in patients with von Willebrand disease and platelet von Willebrand factor deficiency. Br J Haematol 1998; 103: 20–28
   PubMedGoogle Scholar
• Hayward CP, Song Z, Zheng S, Fung R, Pai M, Masse JM, Cramer EM. Multimerin processing by cells with and without pathways for regulated protein secretion. Blood 1999; 94: 1337–1347
   PubMedGoogle Scholar
• Hayward CP. Platelet multimerin and its proteolytic processing. Thromb Haemost 1999; 82: 1779–1780
   PubMedGoogle Scholar
• Hayward CP, Weiss HJ, Lages B, Finlay M, Hegstad AC, Zheng S, Cowie A, Masse JM, Harrison P, Cramer EM. The storage defects in grey platelet syndrome and alphadelta-storage pool deficiency affect alpha-granule factor V and multimerin storage without altering their proteolytic processing. Br J Haematol 2001; 113: 871–877
   PubMedGoogle Scholar
• Kahr WH, Zheng S, Sheth PM, Pai M, Cowie A, Bouchard M, Podor TJ, Rivard GE, Hayward CP. Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator. Blood 2001; 98: 257–265
   PubMed Web of Science ®Google Scholar
• Veljkovic DK, Cramer EM, Alimardani G, Fichelson S, Masse JM, Hayward CP. Studies of alpha-granule proteins in cultured human megakaryocytes. Thromb Haemost 2003; 90: 844–852
   PubMedGoogle Scholar
• Hayward CP, Fuller N, Zheng S, Adam F, Jeimy SB, Horsewood I, Quinn-Allen MA, Kane WH. Human platelets contain forms of factor V in disulfide-linkage with multimerin. Thromb Haemost 2004; 92: 1349–1357
   PubMedGoogle Scholar
• Jeimy SB, Woram RA, Fuller N, Quinn-Allen MA, Nicolaes GA, Dahlback B, Kane WH, Hayward CP. Identification of the MMRN1 binding region within the C2 domain of human factor V. J Biol Chem 2004; 279: 51466–51471
   PubMedGoogle Scholar
• Adam F, Zheng S, Joshi N, Kelton DS, Sandhu A, Suehiro Y, Jeimy SB, Santos AV, Masse JM, Kelton JG, et al. Analyses of cellular multimerin 1 receptors: In vitro evidence of binding mediated by alphaIIbbeta3 and alphavbeta3. Thromb Haemost 2005; 94: 1004–1011
   PubMedGoogle Scholar
• Suehiro Y, Veljkovic DK, Fuller N, Motomura Y, Masse JM, Cramer EM, Hayward CP. Endocytosis and storage of plasma factor V by human megakaryocytes. Thromb Haemost 2005; 94: 585–592
   PubMedGoogle Scholar
• Bienz D, Clemetson KJ. Human platelet glycoprotein Ia. One component is only expressed on the surface of activated platelets and may be a granule constituent. J Biol Chem 1989; 264: 507–514
   PubMedGoogle Scholar
• Polgar J, Magnenat E, Wells TN, Clemetson KJ. Platelet glycoprotein Ia* is the processed form of multimerin–isolation and determination of N-terminal sequences of stored and released forms. Thromb Haemost 1998; 80: 645–648
   PubMedGoogle Scholar
• Colombatti A, Doliana R, Bot S, Canton A, Mongiat M, Mungiguerra G, Paron-Cilli S, Spessotto P. The EMILIN protein family. Matrix Biol 2000; 19: 289–301
   PubMed Web of Science ®Google Scholar
• Doliana R, Canton A, Bucciotti F, Mongiat M, Bonaldo P, Colombatti A. Structure, chromosomal localization, and promoter analysis of the human elastin microfibril interfase located proteIN (EMILIN) gene. J Biol Chem 2000; 275: 785–792
   PubMedGoogle Scholar
• Doliana R, Mongiat M, Bucciotti F, Giacomello E, Deutzmann R, Volpin D, Bressan GM, Colombatti A. EMILIN, a component of the elastic fiber and a new member of the C1q/tumor necrosis factor superfamily of proteins. J Biol Chem 1999; 274: 16773–16781
   PubMed Web of Science ®Google Scholar
• Haberichter S, Montgomery R. Structure and function of von Willebrand factor. Hemostasis and thrombosis: Basic principles and clinical practice, RW Colman, VJ Marder, A Clowes, JN George, SZ Goldhaber. Lippincott and Williams, Philadelphia 2006; 707–722
   Google Scholar
• Torres MD, Van Tuinen P, Kroner PA. The human multimerin gene MMRN maps to chromosome 4q22. Cytogenet Cell Genet 2000; 88: 275–277
   PubMedGoogle Scholar
• Balduini A, d'Apolito M, Arcelli D, Conti V, Pecci A, Pietra D, Danova M, Benvenuto F, Perotti C, Zelante L, et al. Cord blood in vitro expanded CD41 cells: Identification of novel components of megakaryocytopoiesis. J Thromb Haemost 2006; 4: 848–860
   PubMedGoogle Scholar
• Gevaert K, Goethals M, Martens L, Van DJ, Staes A, Thomas GR, Vandekerckhove J. Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat Biotechnol 2003; 21: 566–569
   PubMed Web of Science ®Google Scholar
• Garcia A, Prabhakar S, Brock CJ, Pearce AC, Dwek RA, Watson SP, Hebestreit HF, Zitzmann N. Extensive analysis of the human platelet proteome by two-dimensional gel electrophoresis and mass spectrometry. Proteomics 2004; 4: 656–668
   PubMed Web of Science ®Google Scholar
• Braghetta P, Ferrari A, de GP, Zanetti M, Volpin D, Bonaldo P, Bressan GM. Overlapping, complementary and site-specific expression pattern of genes of the EMILIN/Multimerin family. Matrix Biol 2004; 22: 549–556
   PubMed Web of Science ®Google Scholar
• Christian S, Ahorn H, Novatchkova M, Garin-Chesa P, Park JE, Weber G, Eisenhaber F, Rettig WJ, Lenter MC. Molecular cloning and characterization of EndoGlyx-1, an EMILIN-like multisubunit glycoprotein of vascular endothelium. J Biol Chem 2001; 276: 48588–48595
   PubMed Web of Science ®Google Scholar
• Lewandrowski U, Moebius J, Walter U, Sickmann A. Elucidation of N-glycosylation sites on human platelet proteins: A glycoproteomic approach. Mol Cell Proteomics 2006; 5: 226–233
   PubMed Web of Science ®Google Scholar
• Vullo A, Frasconi P. Disulfide connectivity prediction using recursive neural networks and evolutionary information. Bioinformatics 2004; 20: 653–659
   PubMedGoogle Scholar
• Sigrist CJ, Cerutti L, Hulo N, Gattiker A, Falquet L, Pagni M, Bairoch A, Bucher P. PROSITE: A documented database using patterns and profiles as motif descriptors. Brief Bioinform 2002; 3: 265–274
   PubMedGoogle Scholar
• Doliana R, Bot S, Bonaldo P, Colombatti A. EMI, a novel cysteine-rich domain of EMILINs and other extracellular proteins, interacts with the gC1q domains and participates in multimerization. FEBS Lett 2000; 484: 164–168
   PubMedGoogle Scholar
• Braghetta P, Ferrari A, de GP, Zanetti M, Volpin D, Bonaldo P, Bressan GM. Expression of the EMILIN-1 gene during mouse development. Matrix Biol 2002; 21: 603–609
   PubMed Web of Science ®Google Scholar
• Leimeister C, Steidl C, Schumacher N, Erhard S, Gessler M. Developmental expression and biochemical characterization of Emu family members. Dev Biol 2002; 249: 204–218
   PubMedGoogle Scholar
• Acton S, Resnick D, Freeman M, Ekkel Y, Ashkenas J, Krieger M. The collagenous domains of macrophage scavenger receptors and complement component C1q mediate their similar, but not identical, binding specificities for polyanionic ligands. J Biol Chem 1993; 268: 3530–3537
   PubMed Web of Science ®Google Scholar
• Brass A, Kadler KE, Thomas JT, Grant ME, Boot-Handford RP. The fibrillar collagens, collagen VIII, collagen X and the C1q complement proteins share a similar domain in their C-terminal non-collagenous regions. FEBS Lett 1992; 303: 126–128
   PubMedGoogle Scholar
• Kaul M, Loos M. Collagen-like complement component C1q is a membrane protein of human monocyte-derived macrophages that mediates endocytosis. J Immunol 1995; 155: 5795–5802
   PubMedGoogle Scholar
• Smith KF, Haris PI, Chapman D, Reid KB, Perkins SJ. Beta-sheet secondary structure of the trimeric globular domain of C1q of complement and collagen types VIII and X by Fourier-transform infrared spectroscopy and averaged structure predictions. Biochem J 1994; 301(Pt 1)249–256
   PubMedGoogle Scholar
• Mongiat M, Mungiguerra G, Bot S, Mucignat MT, Giacomello E, Doliana R, Colombatti A. Self-assembly and supramolecular organization of EMILIN. J Biol Chem 2000; 275: 25471–25480
   PubMed Web of Science ®Google Scholar
• Shapiro L, Scherer PE. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr Biol 1998; 8: 335–338
   PubMed Web of Science ®Google Scholar
• Spessotto P, Cervi M, Mucignat MT, Mungiguerra G, Sartoretto I, Doliana R, Colombatti A. beta 1 Integrin-dependent cell adhesion to EMILIN-1 is mediated by the gC1q domain. J Biol Chem 2003; 278: 6160–6167
   PubMedGoogle Scholar
• Poels J, Vanden BJ. Insect basic leucine zipper proteins and their role in cyclic AMP-dependent regulation of gene expression. Int Rev Cytol 2004; 241: 277–309
   PubMedGoogle Scholar
• Hulme JT, Scheuer T, Catterall WA. Regulation of cardiac ion channels by signaling complexes: Role of modified leucine zipper motifs. J Mol Cell Cardiol 2004; 37: 625–631
   PubMedGoogle Scholar
• Vinson CR, Sigler PB, McKnight SL. Scissors-grip model for DNA recognition by a family of leucine zipper proteins. Science 1989; 246: 911–916
   PubMed Web of Science ®Google Scholar
• Bork P, Downing AK, Kieffer B, Campbell ID. Structure and distribution of modules in extracellular proteins. Q Rev Biophys 1996; 29: 119–167
   PubMed Web of Science ®Google Scholar
• Appella E, Weber IT, Blasi F. Structure and function of epidermal growth factor-like regions in proteins. FEBS Lett 1988; 231: 1–4
   PubMed Web of Science ®Google Scholar
• Zanetti M, Braghetta P, Sabatelli P, Mura I, Doliana R, Colombatti A, Volpin D, Bonaldo P, Bressan GM. EMILIN-1 deficiency induces elastogenesis and vascular cell defects. Mol Cell Biol 2004; 24: 638–650
   PubMed Web of Science ®Google Scholar
• Diamandis M, Veljkovic DK, Maurer-Spurej E, Rivard GE, Hayward CPM. The Quebec Platelet Disorder: Features, Pathogenesis and Treatment. Blood Coag Fibrinol 2008; 19: 109–119
   PubMedGoogle Scholar
• Sheth PM, Kahr WH, Haq MA, Veljkovic DK, Rivard GE, Hayward CP. Intracellular activation of the fibrinolytic cascade in the Quebec Platelet Disorder. Thromb Haemost 2003; 90: 293–298
   PubMed Web of Science ®Google Scholar
• Michaux G, Pullen TJ, Haberichter SL, Cutler DF. P-selectin binds to the D'-D3 domains of von Willebrand factor in Weibel-Palade bodies. Blood 2006; 107: 3922–3924
   PubMedGoogle Scholar
• Ni H, Denis CV, Subbarao S, Degen JL, Sato TN, Hynes RO, Wagner DD. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest 2000; 106: 385–392
   PubMed Web of Science ®Google Scholar
• Sottile J, Hocking DC. Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions. Mol Biol Cell 2002; 13: 3546–3559
   PubMed Web of Science ®Google Scholar
• Kane WH, Factor V. Hemostasis and thrombosis: Basic principles and clinical practice. 4th ed., RW Colman, VJ Marder, A Clowes, JN George, SZ Goldhaber. J.B. Lippincott Company, Philadelphia 2006; 177–192
   Google Scholar
• Tracy PB, Eide LL, Bowie EJ, Mann KG. Radioimmunoassay of factor V in human plasma and platelets. Blood 1982; 60: 59–63
   PubMed Web of Science ®Google Scholar
• Fay PJ. Activation of factor VIII and mechanisms of cofactor action. Blood Rev 2004; 18: 1–15
   PubMed Web of Science ®Google Scholar
• Specht CG, Schoepfer R. Deletion of multimerin-1 in alpha-synuclein-deficient mice. Genomics 2004; 83: 1176–1178
   PubMed Web of Science ®Google Scholar
• Nowaczyk MJ, Teshima IE, Siegel-Bartelt J, Clarke JT. Deletion 4q21/4q22 syndrome: Two patients with de novo 4q21.3q23 and 4q13.2q23 deletions. Am J Med Genet 1997; 69: 400–405
   PubMedGoogle Scholar
• Harada N, Nagai T, Shimokawa O, Niikawa N, Matsumoto N. A 4q21–q22 deletion in a girl with severe growth retardation. Clin Genet 2002; 61: 226–228
   PubMedGoogle Scholar
• Weiss HJ, Lages B, Zheng S, Hayward CP. Platelet factor V New York: A defect in factor V distinct from that in factor V Quebec resulting in impaired prothrombinase generation. Am J Hematol 2001; 66: 130–139
   PubMedGoogle Scholar